Jove
Visualize
Contact Us

Related Experiment Videos

Schistosomal glomerulopathy: selection factors.

R S Barsoum1

  • 1Cairo University, Egypt.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
|January 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glomerulonephritis in disadvantaged populations.

Clinical nephrology·2010
Same author

Spectrum of glomerulonephritis in egypt.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia·2008
Same author

Health-related quality of life in emotionally related kidney transplantation: deductions from a comparative study.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia·2007
Same author

Tropical parasitic nephropathies.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·1999
Same author

Urinary schistosomiasis.

American journal of kidney diseases : the official journal of the National Kidney Foundation·1998
Same author

Malarial nephropathies.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·1998
Same journal

Correction to: Hyponatraemia-treatment standard 2024.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same journal

Effect of Semaglutide on Measured vs Estimated Glomerular Filtration Rate.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same journal

Beyond Diffusion and Convection: Is Adsorption the Third Dimension of Dialysis?

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same journal

Pivotal Clinical Trials in C3 Glomerulopathy: answers and remaining uncertainties.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same journal

Urinary protein vs albumin for assessing kidney failure risk in chronic kidney disease.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same journal

Systolic blood pressure and albuminuria reduction mediate cardiovascular benefits of finerenone in T2 diabetes and CKD.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Schistosomiasis affects millions, but few develop kidney disease. Impaired liver macrophage function, parasitic species, and genetics are key factors in developing schistosoma-associated glomerulopathies.

Area of Science:

  • Immunology
  • Nephrology
  • Infectious Diseases

Background:

  • Schistosomiasis affects hundreds of millions globally.
  • Immune-mediated glomerulopathies are rare complications of schistosomiasis.
  • Factors influencing disease development are not fully understood.

Purpose of the Study:

  • To review and highlight factors contributing to schistosoma-associated glomerulopathies.
  • To discuss the role of parasitic species, co-infections, and host genetics.
  • To emphasize the importance of hepatic macrophage activity.

Main Methods:

  • Review of experimental and clinical evidence.
  • Analysis of factors including parasitic species, salmonellosis, genetic predisposition, and hepatic macrophage function.

Related Experiment Videos

  • Discussion of parasite strains, infestation intensity, hepatitis B, and urinary pathogens.

    • Main Results:

    • Parasitic species, salmonellosis, genetic predisposition, and impaired hepatic macrophage activity are important factors.
    • Parasite strains, infestation intensity, hepatitis B, and urinary pathogens may also play a role.
    • Inefficient hepatic macrophage system is crucial, allowing antigen and IgA polymer escape.

    Conclusions:

    • Development of glomerulopathies in schistosomiasis is multifactorial.
    • Hepatic macrophage inefficiency is a key factor in disease pathogenesis.
    • Further research into these factors could inform prevention and treatment strategies.